AI Prostate Cancer Test Enters Clinical Use in Puerto Rico

CorePlus Integrates AI-Powered Prostate Cancer Risk Stratification Tool into its Digital Pathology Diagnostic Pathway — a First in Puerto Rico

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, becoming the first laboratory in Puerto Rico to bring this guideline-recommended AI test into routine clinical use, allowing for fast and convenient delivery of treatment insights. The ArteraAI more... The post CorePlus Integrates AI…

AI Prostate Cancer Test Enters Clinical Use in Puerto Rico

The test analyzes digital biopsy images to help predict treatment response and long-term outcomes for patients with localized prostate cancer. CorePlus, a digital clinical laboratory in Puerto Rico, has integrated the ArteraAI Prostate Test into its diagnostic workflow. This marks the first time the artificial intelligence test has been brought into routine clinical use in the region to provide treatment insights for localized prostate cancer. T…